Global Parkinson’s Disease Treatment Market Growth (Status and Outlook) 2025-2031
According to this study, the global Parkinson’s Disease Treatment market size will reach US$ million by 2031.
Parkinson’s disease (PD) is a chronic and progressive disease, considered an idiopathic form, and accounts for roughly 80% of the cases of Parkinsonism—neurological disorders that lead to movement problems. While the exact cause of Parkinson’s disease is unknown, it may include a number of factors such as aging, environmental factors/exposures, and genetic predispositions.
United States market for Parkinson’s Disease Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Parkinson’s Disease Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Parkinson’s Disease Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Parkinson’s Disease Treatment players cover Teva, Roche, Prothena, Acorda Therapeutics, Voyager Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Parkinson’s Disease Treatment Industry Forecast” looks at past sales and reviews total world Parkinson’s Disease Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Parkinson’s Disease Treatment sales for 2025 through 2031. With Parkinson’s Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Parkinson’s Disease Treatment industry.
This Insight Report provides a comprehensive analysis of the global Parkinson’s Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Parkinson’s Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Parkinson’s Disease Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Parkinson’s Disease Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Parkinson’s Disease Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Parkinson’s Disease Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
Parkinson’s disease (PD) is a chronic and progressive disease, considered an idiopathic form, and accounts for roughly 80% of the cases of Parkinsonism—neurological disorders that lead to movement problems. While the exact cause of Parkinson’s disease is unknown, it may include a number of factors such as aging, environmental factors/exposures, and genetic predispositions.
United States market for Parkinson’s Disease Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Parkinson’s Disease Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Parkinson’s Disease Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Parkinson’s Disease Treatment players cover Teva, Roche, Prothena, Acorda Therapeutics, Voyager Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Parkinson’s Disease Treatment Industry Forecast” looks at past sales and reviews total world Parkinson’s Disease Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Parkinson’s Disease Treatment sales for 2025 through 2031. With Parkinson’s Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Parkinson’s Disease Treatment industry.
This Insight Report provides a comprehensive analysis of the global Parkinson’s Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Parkinson’s Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Parkinson’s Disease Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Parkinson’s Disease Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Parkinson’s Disease Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Parkinson’s Disease Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Oral
- Transdermal
- Subcutaneous
- Intestinal Infusion
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva
- Roche
- Prothena
- Acorda Therapeutics
- Voyager Therapeutics
- Impax Pharmaceuticals
- UCB
- AbbVie
- MSD
- Orion Pharmaceuticals
- Intec Pharma
- NeuroDerm
- Adamas Therapeutics
- Acadia
- Sunovion
- GSK
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parkinson’s Disease Treatment Market Size (2020-2031)
2.1.2 Parkinson’s Disease Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Parkinson’s Disease Treatment by Country/Region (2020, 2024 & 2031)
2.2 Parkinson’s Disease Treatment Segment by Type
2.2.1 Oral
2.2.2 Transdermal
2.2.3 Subcutaneous
2.2.4 Intestinal Infusion
2.3 Parkinson’s Disease Treatment Market Size by Type
2.3.1 Parkinson’s Disease Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Parkinson’s Disease Treatment Market Size Market Share by Type (2020-2025)
2.4 Parkinson’s Disease Treatment Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.5 Parkinson’s Disease Treatment Market Size by Application
2.5.1 Parkinson’s Disease Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Parkinson’s Disease Treatment Market Size Market Share by Application (2020-2025)
3 PARKINSON’S DISEASE TREATMENT MARKET SIZE BY PLAYER
3.1 Parkinson’s Disease Treatment Market Size Market Share by Player
3.1.1 Global Parkinson’s Disease Treatment Revenue by Player (2020-2025)
3.1.2 Global Parkinson’s Disease Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Parkinson’s Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PARKINSON’S DISEASE TREATMENT BY REGION
4.1 Parkinson’s Disease Treatment Market Size by Region (2020-2025)
4.2 Global Parkinson’s Disease Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Parkinson’s Disease Treatment Market Size Growth (2020-2025)
4.4 APAC Parkinson’s Disease Treatment Market Size Growth (2020-2025)
4.5 Europe Parkinson’s Disease Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Parkinson’s Disease Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Parkinson’s Disease Treatment Market Size by Country (2020-2025)
5.2 Americas Parkinson’s Disease Treatment Market Size by Type (2020-2025)
5.3 Americas Parkinson’s Disease Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parkinson’s Disease Treatment Market Size by Region (2020-2025)
6.2 APAC Parkinson’s Disease Treatment Market Size by Type (2020-2025)
6.3 APAC Parkinson’s Disease Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Parkinson’s Disease Treatment Market Size by Country (2020-2025)
7.2 Europe Parkinson’s Disease Treatment Market Size by Type (2020-2025)
7.3 Europe Parkinson’s Disease Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parkinson’s Disease Treatment by Region (2020-2025)
8.2 Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PARKINSON’S DISEASE TREATMENT MARKET FORECAST
10.1 Global Parkinson’s Disease Treatment Forecast by Region (2026-2031)
10.1.1 Global Parkinson’s Disease Treatment Forecast by Region (2026-2031)
10.1.2 Americas Parkinson’s Disease Treatment Forecast
10.1.3 APAC Parkinson’s Disease Treatment Forecast
10.1.4 Europe Parkinson’s Disease Treatment Forecast
10.1.5 Middle East & Africa Parkinson’s Disease Treatment Forecast
10.2 Americas Parkinson’s Disease Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Parkinson’s Disease Treatment Forecast
10.2.2 Canada Market Parkinson’s Disease Treatment Forecast
10.2.3 Mexico Market Parkinson’s Disease Treatment Forecast
10.2.4 Brazil Market Parkinson’s Disease Treatment Forecast
10.3 APAC Parkinson’s Disease Treatment Forecast by Region (2026-2031)
10.3.1 China Parkinson’s Disease Treatment Market Forecast
10.3.2 Japan Market Parkinson’s Disease Treatment Forecast
10.3.3 Korea Market Parkinson’s Disease Treatment Forecast
10.3.4 Southeast Asia Market Parkinson’s Disease Treatment Forecast
10.3.5 India Market Parkinson’s Disease Treatment Forecast
10.3.6 Australia Market Parkinson’s Disease Treatment Forecast
10.4 Europe Parkinson’s Disease Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Parkinson’s Disease Treatment Forecast
10.4.2 France Market Parkinson’s Disease Treatment Forecast
10.4.3 UK Market Parkinson’s Disease Treatment Forecast
10.4.4 Italy Market Parkinson’s Disease Treatment Forecast
10.4.5 Russia Market Parkinson’s Disease Treatment Forecast
10.5 Middle East & Africa Parkinson’s Disease Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Parkinson’s Disease Treatment Forecast
10.5.2 South Africa Market Parkinson’s Disease Treatment Forecast
10.5.3 Israel Market Parkinson’s Disease Treatment Forecast
10.5.4 Turkey Market Parkinson’s Disease Treatment Forecast
10.6 Global Parkinson’s Disease Treatment Forecast by Type (2026-2031)
10.7 Global Parkinson’s Disease Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Parkinson’s Disease Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Parkinson’s Disease Treatment Product Offered
11.1.3 Teva Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Parkinson’s Disease Treatment Product Offered
11.2.3 Roche Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Prothena
11.3.1 Prothena Company Information
11.3.2 Prothena Parkinson’s Disease Treatment Product Offered
11.3.3 Prothena Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Prothena Main Business Overview
11.3.5 Prothena Latest Developments
11.4 Acorda Therapeutics
11.4.1 Acorda Therapeutics Company Information
11.4.2 Acorda Therapeutics Parkinson’s Disease Treatment Product Offered
11.4.3 Acorda Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Acorda Therapeutics Main Business Overview
11.4.5 Acorda Therapeutics Latest Developments
11.5 Voyager Therapeutics
11.5.1 Voyager Therapeutics Company Information
11.5.2 Voyager Therapeutics Parkinson’s Disease Treatment Product Offered
11.5.3 Voyager Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Voyager Therapeutics Main Business Overview
11.5.5 Voyager Therapeutics Latest Developments
11.6 Impax Pharmaceuticals
11.6.1 Impax Pharmaceuticals Company Information
11.6.2 Impax Pharmaceuticals Parkinson’s Disease Treatment Product Offered
11.6.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Impax Pharmaceuticals Main Business Overview
11.6.5 Impax Pharmaceuticals Latest Developments
11.7 UCB
11.7.1 UCB Company Information
11.7.2 UCB Parkinson’s Disease Treatment Product Offered
11.7.3 UCB Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 UCB Main Business Overview
11.7.5 UCB Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Parkinson’s Disease Treatment Product Offered
11.8.3 AbbVie Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 MSD
11.9.1 MSD Company Information
11.9.2 MSD Parkinson’s Disease Treatment Product Offered
11.9.3 MSD Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 MSD Main Business Overview
11.9.5 MSD Latest Developments
11.10 Orion Pharmaceuticals
11.10.1 Orion Pharmaceuticals Company Information
11.10.2 Orion Pharmaceuticals Parkinson’s Disease Treatment Product Offered
11.10.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Orion Pharmaceuticals Main Business Overview
11.10.5 Orion Pharmaceuticals Latest Developments
11.11 Intec Pharma
11.11.1 Intec Pharma Company Information
11.11.2 Intec Pharma Parkinson’s Disease Treatment Product Offered
11.11.3 Intec Pharma Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Intec Pharma Main Business Overview
11.11.5 Intec Pharma Latest Developments
11.12 NeuroDerm
11.12.1 NeuroDerm Company Information
11.12.2 NeuroDerm Parkinson’s Disease Treatment Product Offered
11.12.3 NeuroDerm Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 NeuroDerm Main Business Overview
11.12.5 NeuroDerm Latest Developments
11.13 Adamas Therapeutics
11.13.1 Adamas Therapeutics Company Information
11.13.2 Adamas Therapeutics Parkinson’s Disease Treatment Product Offered
11.13.3 Adamas Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Adamas Therapeutics Main Business Overview
11.13.5 Adamas Therapeutics Latest Developments
11.14 Acadia
11.14.1 Acadia Company Information
11.14.2 Acadia Parkinson’s Disease Treatment Product Offered
11.14.3 Acadia Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Acadia Main Business Overview
11.14.5 Acadia Latest Developments
11.15 Sunovion
11.15.1 Sunovion Company Information
11.15.2 Sunovion Parkinson’s Disease Treatment Product Offered
11.15.3 Sunovion Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Sunovion Main Business Overview
11.15.5 Sunovion Latest Developments
11.16 GSK
11.16.1 GSK Company Information
11.16.2 GSK Parkinson’s Disease Treatment Product Offered
11.16.3 GSK Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 GSK Main Business Overview
11.16.5 GSK Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parkinson’s Disease Treatment Market Size (2020-2031)
2.1.2 Parkinson’s Disease Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Parkinson’s Disease Treatment by Country/Region (2020, 2024 & 2031)
2.2 Parkinson’s Disease Treatment Segment by Type
2.2.1 Oral
2.2.2 Transdermal
2.2.3 Subcutaneous
2.2.4 Intestinal Infusion
2.3 Parkinson’s Disease Treatment Market Size by Type
2.3.1 Parkinson’s Disease Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Parkinson’s Disease Treatment Market Size Market Share by Type (2020-2025)
2.4 Parkinson’s Disease Treatment Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.5 Parkinson’s Disease Treatment Market Size by Application
2.5.1 Parkinson’s Disease Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Parkinson’s Disease Treatment Market Size Market Share by Application (2020-2025)
3 PARKINSON’S DISEASE TREATMENT MARKET SIZE BY PLAYER
3.1 Parkinson’s Disease Treatment Market Size Market Share by Player
3.1.1 Global Parkinson’s Disease Treatment Revenue by Player (2020-2025)
3.1.2 Global Parkinson’s Disease Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Parkinson’s Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PARKINSON’S DISEASE TREATMENT BY REGION
4.1 Parkinson’s Disease Treatment Market Size by Region (2020-2025)
4.2 Global Parkinson’s Disease Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Parkinson’s Disease Treatment Market Size Growth (2020-2025)
4.4 APAC Parkinson’s Disease Treatment Market Size Growth (2020-2025)
4.5 Europe Parkinson’s Disease Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Parkinson’s Disease Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Parkinson’s Disease Treatment Market Size by Country (2020-2025)
5.2 Americas Parkinson’s Disease Treatment Market Size by Type (2020-2025)
5.3 Americas Parkinson’s Disease Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parkinson’s Disease Treatment Market Size by Region (2020-2025)
6.2 APAC Parkinson’s Disease Treatment Market Size by Type (2020-2025)
6.3 APAC Parkinson’s Disease Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Parkinson’s Disease Treatment Market Size by Country (2020-2025)
7.2 Europe Parkinson’s Disease Treatment Market Size by Type (2020-2025)
7.3 Europe Parkinson’s Disease Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parkinson’s Disease Treatment by Region (2020-2025)
8.2 Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PARKINSON’S DISEASE TREATMENT MARKET FORECAST
10.1 Global Parkinson’s Disease Treatment Forecast by Region (2026-2031)
10.1.1 Global Parkinson’s Disease Treatment Forecast by Region (2026-2031)
10.1.2 Americas Parkinson’s Disease Treatment Forecast
10.1.3 APAC Parkinson’s Disease Treatment Forecast
10.1.4 Europe Parkinson’s Disease Treatment Forecast
10.1.5 Middle East & Africa Parkinson’s Disease Treatment Forecast
10.2 Americas Parkinson’s Disease Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Parkinson’s Disease Treatment Forecast
10.2.2 Canada Market Parkinson’s Disease Treatment Forecast
10.2.3 Mexico Market Parkinson’s Disease Treatment Forecast
10.2.4 Brazil Market Parkinson’s Disease Treatment Forecast
10.3 APAC Parkinson’s Disease Treatment Forecast by Region (2026-2031)
10.3.1 China Parkinson’s Disease Treatment Market Forecast
10.3.2 Japan Market Parkinson’s Disease Treatment Forecast
10.3.3 Korea Market Parkinson’s Disease Treatment Forecast
10.3.4 Southeast Asia Market Parkinson’s Disease Treatment Forecast
10.3.5 India Market Parkinson’s Disease Treatment Forecast
10.3.6 Australia Market Parkinson’s Disease Treatment Forecast
10.4 Europe Parkinson’s Disease Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Parkinson’s Disease Treatment Forecast
10.4.2 France Market Parkinson’s Disease Treatment Forecast
10.4.3 UK Market Parkinson’s Disease Treatment Forecast
10.4.4 Italy Market Parkinson’s Disease Treatment Forecast
10.4.5 Russia Market Parkinson’s Disease Treatment Forecast
10.5 Middle East & Africa Parkinson’s Disease Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Parkinson’s Disease Treatment Forecast
10.5.2 South Africa Market Parkinson’s Disease Treatment Forecast
10.5.3 Israel Market Parkinson’s Disease Treatment Forecast
10.5.4 Turkey Market Parkinson’s Disease Treatment Forecast
10.6 Global Parkinson’s Disease Treatment Forecast by Type (2026-2031)
10.7 Global Parkinson’s Disease Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Parkinson’s Disease Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Parkinson’s Disease Treatment Product Offered
11.1.3 Teva Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Parkinson’s Disease Treatment Product Offered
11.2.3 Roche Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Prothena
11.3.1 Prothena Company Information
11.3.2 Prothena Parkinson’s Disease Treatment Product Offered
11.3.3 Prothena Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Prothena Main Business Overview
11.3.5 Prothena Latest Developments
11.4 Acorda Therapeutics
11.4.1 Acorda Therapeutics Company Information
11.4.2 Acorda Therapeutics Parkinson’s Disease Treatment Product Offered
11.4.3 Acorda Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Acorda Therapeutics Main Business Overview
11.4.5 Acorda Therapeutics Latest Developments
11.5 Voyager Therapeutics
11.5.1 Voyager Therapeutics Company Information
11.5.2 Voyager Therapeutics Parkinson’s Disease Treatment Product Offered
11.5.3 Voyager Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Voyager Therapeutics Main Business Overview
11.5.5 Voyager Therapeutics Latest Developments
11.6 Impax Pharmaceuticals
11.6.1 Impax Pharmaceuticals Company Information
11.6.2 Impax Pharmaceuticals Parkinson’s Disease Treatment Product Offered
11.6.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Impax Pharmaceuticals Main Business Overview
11.6.5 Impax Pharmaceuticals Latest Developments
11.7 UCB
11.7.1 UCB Company Information
11.7.2 UCB Parkinson’s Disease Treatment Product Offered
11.7.3 UCB Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 UCB Main Business Overview
11.7.5 UCB Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Parkinson’s Disease Treatment Product Offered
11.8.3 AbbVie Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 MSD
11.9.1 MSD Company Information
11.9.2 MSD Parkinson’s Disease Treatment Product Offered
11.9.3 MSD Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 MSD Main Business Overview
11.9.5 MSD Latest Developments
11.10 Orion Pharmaceuticals
11.10.1 Orion Pharmaceuticals Company Information
11.10.2 Orion Pharmaceuticals Parkinson’s Disease Treatment Product Offered
11.10.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Orion Pharmaceuticals Main Business Overview
11.10.5 Orion Pharmaceuticals Latest Developments
11.11 Intec Pharma
11.11.1 Intec Pharma Company Information
11.11.2 Intec Pharma Parkinson’s Disease Treatment Product Offered
11.11.3 Intec Pharma Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Intec Pharma Main Business Overview
11.11.5 Intec Pharma Latest Developments
11.12 NeuroDerm
11.12.1 NeuroDerm Company Information
11.12.2 NeuroDerm Parkinson’s Disease Treatment Product Offered
11.12.3 NeuroDerm Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 NeuroDerm Main Business Overview
11.12.5 NeuroDerm Latest Developments
11.13 Adamas Therapeutics
11.13.1 Adamas Therapeutics Company Information
11.13.2 Adamas Therapeutics Parkinson’s Disease Treatment Product Offered
11.13.3 Adamas Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Adamas Therapeutics Main Business Overview
11.13.5 Adamas Therapeutics Latest Developments
11.14 Acadia
11.14.1 Acadia Company Information
11.14.2 Acadia Parkinson’s Disease Treatment Product Offered
11.14.3 Acadia Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Acadia Main Business Overview
11.14.5 Acadia Latest Developments
11.15 Sunovion
11.15.1 Sunovion Company Information
11.15.2 Sunovion Parkinson’s Disease Treatment Product Offered
11.15.3 Sunovion Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Sunovion Main Business Overview
11.15.5 Sunovion Latest Developments
11.16 GSK
11.16.1 GSK Company Information
11.16.2 GSK Parkinson’s Disease Treatment Product Offered
11.16.3 GSK Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 GSK Main Business Overview
11.16.5 GSK Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Parkinson’s Disease Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Parkinson’s Disease Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Transdermal
Table 5. Major Players of Subcutaneous
Table 6. Major Players of Intestinal Infusion
Table 7. Parkinson’s Disease Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Parkinson’s Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Parkinson’s Disease Treatment Market Size Market Share by Type (2020-2025)
Table 10. Parkinson’s Disease Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Parkinson’s Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Parkinson’s Disease Treatment Market Size Market Share by Application (2020-2025)
Table 13. Global Parkinson’s Disease Treatment Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Parkinson’s Disease Treatment Revenue Market Share by Player (2020-2025)
Table 15. Parkinson’s Disease Treatment Key Players Head office and Products Offered
Table 16. Parkinson’s Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Parkinson’s Disease Treatment Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Parkinson’s Disease Treatment Market Size Market Share by Region (2020-2025)
Table 21. Global Parkinson’s Disease Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Parkinson’s Disease Treatment Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Parkinson’s Disease Treatment Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Parkinson’s Disease Treatment Market Size Market Share by Country (2020-2025)
Table 25. Americas Parkinson’s Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Parkinson’s Disease Treatment Market Size Market Share by Type (2020-2025)
Table 27. Americas Parkinson’s Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Parkinson’s Disease Treatment Market Size Market Share by Application (2020-2025)
Table 29. APAC Parkinson’s Disease Treatment Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Parkinson’s Disease Treatment Market Size Market Share by Region (2020-2025)
Table 31. APAC Parkinson’s Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Parkinson’s Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Parkinson’s Disease Treatment Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Parkinson’s Disease Treatment Market Size Market Share by Country (2020-2025)
Table 35. Europe Parkinson’s Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Parkinson’s Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Parkinson’s Disease Treatment Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Parkinson’s Disease Treatment
Table 41. Key Market Challenges & Risks of Parkinson’s Disease Treatment
Table 42. Key Industry Trends of Parkinson’s Disease Treatment
Table 43. Global Parkinson’s Disease Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Parkinson’s Disease Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Parkinson’s Disease Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Parkinson’s Disease Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Teva Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 48. Teva Parkinson’s Disease Treatment Product Offered
Table 49. Teva Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Teva Main Business
Table 51. Teva Latest Developments
Table 52. Roche Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 53. Roche Parkinson’s Disease Treatment Product Offered
Table 54. Roche Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. Prothena Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 58. Prothena Parkinson’s Disease Treatment Product Offered
Table 59. Prothena Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Prothena Main Business
Table 61. Prothena Latest Developments
Table 62. Acorda Therapeutics Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 63. Acorda Therapeutics Parkinson’s Disease Treatment Product Offered
Table 64. Acorda Therapeutics Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Acorda Therapeutics Main Business
Table 66. Acorda Therapeutics Latest Developments
Table 67. Voyager Therapeutics Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 68. Voyager Therapeutics Parkinson’s Disease Treatment Product Offered
Table 69. Voyager Therapeutics Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Voyager Therapeutics Main Business
Table 71. Voyager Therapeutics Latest Developments
Table 72. Impax Pharmaceuticals Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 73. Impax Pharmaceuticals Parkinson’s Disease Treatment Product Offered
Table 74. Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Impax Pharmaceuticals Main Business
Table 76. Impax Pharmaceuticals Latest Developments
Table 77. UCB Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 78. UCB Parkinson’s Disease Treatment Product Offered
Table 79. UCB Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. UCB Main Business
Table 81. UCB Latest Developments
Table 82. AbbVie Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 83. AbbVie Parkinson’s Disease Treatment Product Offered
Table 84. AbbVie Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. AbbVie Main Business
Table 86. AbbVie Latest Developments
Table 87. MSD Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 88. MSD Parkinson’s Disease Treatment Product Offered
Table 89. MSD Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. MSD Main Business
Table 91. MSD Latest Developments
Table 92. Orion Pharmaceuticals Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 93. Orion Pharmaceuticals Parkinson’s Disease Treatment Product Offered
Table 94. Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Orion Pharmaceuticals Main Business
Table 96. Orion Pharmaceuticals Latest Developments
Table 97. Intec Pharma Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 98. Intec Pharma Parkinson’s Disease Treatment Product Offered
Table 99. Intec Pharma Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Intec Pharma Main Business
Table 101. Intec Pharma Latest Developments
Table 102. NeuroDerm Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 103. NeuroDerm Parkinson’s Disease Treatment Product Offered
Table 104. NeuroDerm Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105. NeuroDerm Main Business
Table 106. NeuroDerm Latest Developments
Table 107. Adamas Therapeutics Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 108. Adamas Therapeutics Parkinson’s Disease Treatment Product Offered
Table 109. Adamas Therapeutics Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 110. Adamas Therapeutics Main Business
Table 111. Adamas Therapeutics Latest Developments
Table 112. Acadia Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 113. Acadia Parkinson’s Disease Treatment Product Offered
Table 114. Acadia Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 115. Acadia Main Business
Table 116. Acadia Latest Developments
Table 117. Sunovion Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 118. Sunovion Parkinson’s Disease Treatment Product Offered
Table 119. Sunovion Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 120. Sunovion Main Business
Table 121. Sunovion Latest Developments
Table 122. GSK Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 123. GSK Parkinson’s Disease Treatment Product Offered
Table 124. GSK Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 125. GSK Main Business
Table 126. GSK Latest Developments
Table 1. Parkinson’s Disease Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Parkinson’s Disease Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Transdermal
Table 5. Major Players of Subcutaneous
Table 6. Major Players of Intestinal Infusion
Table 7. Parkinson’s Disease Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Parkinson’s Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Parkinson’s Disease Treatment Market Size Market Share by Type (2020-2025)
Table 10. Parkinson’s Disease Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Parkinson’s Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Parkinson’s Disease Treatment Market Size Market Share by Application (2020-2025)
Table 13. Global Parkinson’s Disease Treatment Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Parkinson’s Disease Treatment Revenue Market Share by Player (2020-2025)
Table 15. Parkinson’s Disease Treatment Key Players Head office and Products Offered
Table 16. Parkinson’s Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Parkinson’s Disease Treatment Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Parkinson’s Disease Treatment Market Size Market Share by Region (2020-2025)
Table 21. Global Parkinson’s Disease Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Parkinson’s Disease Treatment Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Parkinson’s Disease Treatment Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Parkinson’s Disease Treatment Market Size Market Share by Country (2020-2025)
Table 25. Americas Parkinson’s Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Parkinson’s Disease Treatment Market Size Market Share by Type (2020-2025)
Table 27. Americas Parkinson’s Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Parkinson’s Disease Treatment Market Size Market Share by Application (2020-2025)
Table 29. APAC Parkinson’s Disease Treatment Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Parkinson’s Disease Treatment Market Size Market Share by Region (2020-2025)
Table 31. APAC Parkinson’s Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Parkinson’s Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Parkinson’s Disease Treatment Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Parkinson’s Disease Treatment Market Size Market Share by Country (2020-2025)
Table 35. Europe Parkinson’s Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Parkinson’s Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Parkinson’s Disease Treatment Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Parkinson’s Disease Treatment
Table 41. Key Market Challenges & Risks of Parkinson’s Disease Treatment
Table 42. Key Industry Trends of Parkinson’s Disease Treatment
Table 43. Global Parkinson’s Disease Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Parkinson’s Disease Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Parkinson’s Disease Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Parkinson’s Disease Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Teva Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 48. Teva Parkinson’s Disease Treatment Product Offered
Table 49. Teva Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Teva Main Business
Table 51. Teva Latest Developments
Table 52. Roche Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 53. Roche Parkinson’s Disease Treatment Product Offered
Table 54. Roche Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. Prothena Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 58. Prothena Parkinson’s Disease Treatment Product Offered
Table 59. Prothena Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Prothena Main Business
Table 61. Prothena Latest Developments
Table 62. Acorda Therapeutics Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 63. Acorda Therapeutics Parkinson’s Disease Treatment Product Offered
Table 64. Acorda Therapeutics Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Acorda Therapeutics Main Business
Table 66. Acorda Therapeutics Latest Developments
Table 67. Voyager Therapeutics Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 68. Voyager Therapeutics Parkinson’s Disease Treatment Product Offered
Table 69. Voyager Therapeutics Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Voyager Therapeutics Main Business
Table 71. Voyager Therapeutics Latest Developments
Table 72. Impax Pharmaceuticals Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 73. Impax Pharmaceuticals Parkinson’s Disease Treatment Product Offered
Table 74. Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Impax Pharmaceuticals Main Business
Table 76. Impax Pharmaceuticals Latest Developments
Table 77. UCB Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 78. UCB Parkinson’s Disease Treatment Product Offered
Table 79. UCB Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. UCB Main Business
Table 81. UCB Latest Developments
Table 82. AbbVie Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 83. AbbVie Parkinson’s Disease Treatment Product Offered
Table 84. AbbVie Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. AbbVie Main Business
Table 86. AbbVie Latest Developments
Table 87. MSD Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 88. MSD Parkinson’s Disease Treatment Product Offered
Table 89. MSD Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. MSD Main Business
Table 91. MSD Latest Developments
Table 92. Orion Pharmaceuticals Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 93. Orion Pharmaceuticals Parkinson’s Disease Treatment Product Offered
Table 94. Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Orion Pharmaceuticals Main Business
Table 96. Orion Pharmaceuticals Latest Developments
Table 97. Intec Pharma Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 98. Intec Pharma Parkinson’s Disease Treatment Product Offered
Table 99. Intec Pharma Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Intec Pharma Main Business
Table 101. Intec Pharma Latest Developments
Table 102. NeuroDerm Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 103. NeuroDerm Parkinson’s Disease Treatment Product Offered
Table 104. NeuroDerm Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105. NeuroDerm Main Business
Table 106. NeuroDerm Latest Developments
Table 107. Adamas Therapeutics Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 108. Adamas Therapeutics Parkinson’s Disease Treatment Product Offered
Table 109. Adamas Therapeutics Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 110. Adamas Therapeutics Main Business
Table 111. Adamas Therapeutics Latest Developments
Table 112. Acadia Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 113. Acadia Parkinson’s Disease Treatment Product Offered
Table 114. Acadia Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 115. Acadia Main Business
Table 116. Acadia Latest Developments
Table 117. Sunovion Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 118. Sunovion Parkinson’s Disease Treatment Product Offered
Table 119. Sunovion Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 120. Sunovion Main Business
Table 121. Sunovion Latest Developments
Table 122. GSK Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 123. GSK Parkinson’s Disease Treatment Product Offered
Table 124. GSK Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 125. GSK Main Business
Table 126. GSK Latest Developments
LIST OF FIGURES
Figure 1. Parkinson’s Disease Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parkinson’s Disease Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Parkinson’s Disease Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Parkinson’s Disease Treatment Sales Market Share by Country/Region (2024)
Figure 8. Parkinson’s Disease Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Parkinson’s Disease Treatment Market Size Market Share by Type in 2024
Figure 10. Parkinson’s Disease Treatment in Hospital Pharmacy
Figure 11. Global Parkinson’s Disease Treatment Market: Hospital Pharmacy (2020-2025) & ($ millions)
Figure 12. Parkinson’s Disease Treatment in Retail Pharmacy
Figure 13. Global Parkinson’s Disease Treatment Market: Retail Pharmacy (2020-2025) & ($ millions)
Figure 14. Parkinson’s Disease Treatment in Online Pharmacy
Figure 15. Global Parkinson’s Disease Treatment Market: Online Pharmacy (2020-2025) & ($ millions)
Figure 16. Global Parkinson’s Disease Treatment Market Size Market Share by Application in 2024
Figure 17. Global Parkinson’s Disease Treatment Revenue Market Share by Player in 2024
Figure 18. Global Parkinson’s Disease Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Parkinson’s Disease Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Parkinson’s Disease Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Parkinson’s Disease Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Parkinson’s Disease Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Parkinson’s Disease Treatment Value Market Share by Country in 2024
Figure 24. United States Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Parkinson’s Disease Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Parkinson’s Disease Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Parkinson’s Disease Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Parkinson’s Disease Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Parkinson’s Disease Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Parkinson’s Disease Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Parkinson’s Disease Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Parkinson’s Disease Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 1. Parkinson’s Disease Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parkinson’s Disease Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Parkinson’s Disease Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Parkinson’s Disease Treatment Sales Market Share by Country/Region (2024)
Figure 8. Parkinson’s Disease Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Parkinson’s Disease Treatment Market Size Market Share by Type in 2024
Figure 10. Parkinson’s Disease Treatment in Hospital Pharmacy
Figure 11. Global Parkinson’s Disease Treatment Market: Hospital Pharmacy (2020-2025) & ($ millions)
Figure 12. Parkinson’s Disease Treatment in Retail Pharmacy
Figure 13. Global Parkinson’s Disease Treatment Market: Retail Pharmacy (2020-2025) & ($ millions)
Figure 14. Parkinson’s Disease Treatment in Online Pharmacy
Figure 15. Global Parkinson’s Disease Treatment Market: Online Pharmacy (2020-2025) & ($ millions)
Figure 16. Global Parkinson’s Disease Treatment Market Size Market Share by Application in 2024
Figure 17. Global Parkinson’s Disease Treatment Revenue Market Share by Player in 2024
Figure 18. Global Parkinson’s Disease Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Parkinson’s Disease Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Parkinson’s Disease Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Parkinson’s Disease Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Parkinson’s Disease Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Parkinson’s Disease Treatment Value Market Share by Country in 2024
Figure 24. United States Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Parkinson’s Disease Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Parkinson’s Disease Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Parkinson’s Disease Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Parkinson’s Disease Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Parkinson’s Disease Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Parkinson’s Disease Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Parkinson’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Parkinson’s Disease Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Parkinson’s Disease Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Parkinson’s Disease Treatment Market Size 2026-2031 ($ millions)
